Suchergebnisse - "Tonino, Sanne H"

PubPharm (51)

1

The quest for a cure in follicular lymphoma

enthalten in: Blood | 2024

von Tonino, S. | Kersten, M.

CommentOn: Blood. 2024 Feb 8;143(6):496-506. - PMID 37879047

2

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

enthalten in: Blood | 2023

von Acosta-Medina, A. | Kemps, P. | Zondag, T. | +36

3

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

enthalten in: Blood | 2023

von van der Straten, L. | Stege, C. | Kersting, S. | +31

CommentIn: Blood. 2023 Sep 28;142(13):1107-1108. - PMID 37768694

4

A population-based study of transformed marginal zone lymphoma : identifying outcome-related characteristics

enthalten in: Blood cancer journal | 2023

von Bult, J. | Huisman, F. | Zhong, Y. | +10

5

The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia : A study by ERIC, the European research initiative on CLL

enthalten in: American Journal of Hematology | 2023

von Visentin, A. | Chatzikonstantinou, T. | Scarfò, L. | +118

6

Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP

enthalten in: Leukemia | 2022

von Driessen, J. | Kersten, M. | Visser, L. | +20

7

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups : a population-based study in the pre- and post-rituximab era

enthalten in: Leukemia | 2022

von Dinnessen, M. | Maas, C. | Tonino, S. | +6

8

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe) : primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial

enthalten in: The Lancet. Haematology | 2022

von Kersting, S. | Dubois, J. | Nasserinejad, K. | +30

CommentIn: Lancet Haematol. 2022 Mar;9(3):e169-e171. - PMID 35240069

9

How to choose first salvage therapy in Hodgkin lymphoma : traditional chemotherapy vs novel agents

enthalten in: Hematology. American Society of Hematology. Education Program | 2021

von Driessen, J. | Tonino, S. | Moskowitz, A. | +1

10

COVID-19 severity and mortality in patients with CLL : an update of the international ERIC and Campus CLL study

enthalten in: Leukemia | 2021

von Chatzikonstantinou, T. | Kapetanakis, A. | Scarfò, L. | +98

CommentIn: Leukemia. 2022 Feb;36(2):562-565. - PMID 34937858

1
2
3
4
5
6
Nächster »
[6]